← Back to Search

Penile Prosthesis

Inflatable Penile Prosthesis for Erectile Dysfunction

N/A
Recruiting
Led By Paul Perito, MD
Research Sponsored by Rigicon, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 36 months
Awards & highlights
No Placebo-Only Group

Summary

This trial evaluates the long-term safety and effectiveness of a surgically implanted device called Rigicon Infla 10® for men with erectile dysfunction. The device helps men achieve an erection by inflating chambers in the penis. The study will follow patients for an extended period after implantation. This type of device has been used since 1974 to treat erectile dysfunction, with long-term success and high patient satisfaction.

Who is the study for?
Men over 21 with erectile dysfunction can join this trial if they agree to use the Rigicon Infla10® prosthesis as treatment, can follow up on visits and tests, and have no allergies to device materials. Exclusions include those with anesthesia risks, previous penile surgeries, infections at surgery site or systemic infections, limited manual dexterity or mental capacity for device operation, life expectancy under two years, uncontrolled diabetes or significant other health issues.
What is being tested?
The study is testing the safety and effectiveness of the Rigicon Infla10® Three-Piece Inflatable Penile Prosthesis in men with erectile dysfunction over a period of up to three years post-implantation. Participants will be monitored regularly following institutional standards for managing ED and any related conditions.
What are the potential side effects?
Potential side effects may include pain at implant site, infection risk increase due to surgery, mechanical failure of the prosthesis leading to additional interventions or removals. Individual experiences may vary based on personal health factors.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~36 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 36 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Rigidity at 12 months
Survival at 12 months
Secondary study objectives
Serious complications

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Experimental: Rigicon Infla 10® Three-Piece Inflatable Penile Prosthesis GroupExperimental Treatment1 Intervention
Male subjects 21 years of age and older who are implanted with an Rigicon Infla 10® Three-Piece Inflatable Penile Prosthesis for erectile dysfunction.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for Erectile Dysfunction (ED) include PDE5 inhibitors, vacuum erection devices, penile injections, and penile prostheses. PDE5 inhibitors, such as sildenafil, work by enhancing blood flow to the penis by inhibiting the enzyme phosphodiesterase type 5. Vacuum erection devices create an erection by using vacuum pressure to increase blood flow into the penis and occlusive rings to maintain it. Penile injections involve injecting vasodilating agents directly into the penile tissue to induce an erection. Inflatable penile prostheses, like the Rigicon Infla 10® Three-Piece Inflatable Penile Prosthesis, enable an erection by manually pumping fluid into cylinders implanted in the penis, mimicking a natural erection. These treatments are crucial for ED patients as they offer various options to restore sexual function, improve quality of life, and enhance psychological well-being.
Life quality change after inflatable penile prosthesis implantation.Post-prostatectomy erectile dysfunction: contemporary approaches from a US perspective.

Find a Location

Who is running the clinical trial?

Rigicon, Inc.Lead Sponsor
Paul Perito, MDPrincipal InvestigatorPerito Urology - Penile Implant Clinic
Duygu Kirkik, PhDStudy ChairRigicon, Inc.

Media Library

Rigicon Infla 10® Three-Piece Inflatable Penile Prosthesis (Penile Prosthesis) Clinical Trial Eligibility Overview. Trial Name: NCT05574868 — N/A
Erectile Dysfunction Research Study Groups: Experimental: Rigicon Infla 10® Three-Piece Inflatable Penile Prosthesis Group
Erectile Dysfunction Clinical Trial 2023: Rigicon Infla 10® Three-Piece Inflatable Penile Prosthesis Highlights & Side Effects. Trial Name: NCT05574868 — N/A
Rigicon Infla 10® Three-Piece Inflatable Penile Prosthesis (Penile Prosthesis) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05574868 — N/A
~65 spots leftby May 2026